KPV

Also known as: Lys-Pro-Val, Alpha-MSH fragment

ImmunePRECLINICAL

Clinical Status

Preclinical — research ongoing.

Mechanism of Action

Retains the anti-inflammatory properties of alpha-MSH without melanocortin receptor activation. Inhibits NF-kB, reduces pro-inflammatory cytokines, and has antimicrobial properties.

Dosing Defaults

Dose

200-500 mcg

Frequency

1-2x daily

Administration

Subcutaneous injection or oral

Timing

Morning

Food

with or without

Duration

4-8 weeks

Dose range: 100-1000 mcg daily

Morning dosing supports daytime anti-inflammatory effects.

Side Effects

•Injection site reactions
•Mild flu-like symptoms (transient)
•Mild GI effects
•May trigger histamine release

Contraindications & Warnings

⚠Cancer history

•Not medical advice

Compare

Compare KPV with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your KPV dose.

Open Calculator

Related Immune Peptides

LL-37

PHASE 1

Immune

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

Thymosin Alpha-1

PHASE 3

Immune

Thymic peptide for immune modulation. Approved in 35+ countries.

VIP

PHASE 2

Immune

Immunomodulatory peptide used in mold illness (CIRS) protocols.

Thymulin

PRECLINICAL

Immune

Zinc-dependent thymic peptide that promotes T-cell maturation and immune balance.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.